In the EU/EEA, influenza intensity has returned to low levels in most countries and respiratory virus activity is decreasing overall. However, some EU/EEA countries are

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 April 2025 and includes updates on respiratory virus epidemiology in the

Respiratory virus activity is decreasing overall but remains elevated in some EU/EEA countries affected by ongoing flu and/or RSV epidemics. Preventive measures, such as frequent

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 March – 4 April 2025 and includes updates on SARS-CoV-2, Influenza

Respiratory virus activity is decreasing but remains elevated in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly

Respiratory virus activity is currently high in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged to

This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long

COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out

There is currently high respiratory virus activity in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15 – 21 March 2025 and includes updates on cholera, Middle East

Erratum for Euro Surveill. 2021;27(42).

During the ongoing coronavirus disease 2019 (COVID-19) outbreak, robust detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a key element for clinical management